CareFirst Opposes J&J's Bid To Revisit Stelara Antitrust Case
By Matthew Perlman · January 12, 2026, 10:34 PM EST
Insurer CareFirst urged a Virginia federal court to reject Johnson & Johnson's bid for reconsideration of a ruling that refused to toss antitrust and patent fraud claims over the immunosuppressive drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login